Acknowledgement
This work was supported by the National Natural Science Foundation of China (Grant No. 81973727 & 82074493), the Programs of Innovation and Entrepreneurship for Undergraduates of Henan Province (Grant No. S202110459059).
References
- Schirone L, Forte M, D'Ambrosio L, Valenti V, Vecchio D, Schiavon S, Spinosa G, Sarto G, Petrozza V, Frati G, et al. An Overview of the molecular mechanisms associated with myocardial ischemic injury: state of the art and translational perspectives. Cells 2022;11:1165.
- Liu ZY, Zhong QW, Tian CN, Ma HM, Yu JJ, Hu S. NMDA receptor-driven calcium influx promotes ischemic human cardiomyocyte apoptosis through a p38 MAPK-mediated mechanism. J Cell Biochem 2019;120:4872-82. https://doi.org/10.1002/jcb.27702
- Ma JQ, Chen ZW, Ma YJ, Xia Y, Hu K, Zhou Y, Chen A, Qian JY, Ge JB. MicroRNA19a attenuates hypoxia-induced cardiomyocyte apoptosis by downregulating NHE-1 expression and decreasing calcium overload. J Cell Biochem 2020;121:1747-58. https://doi.org/10.1002/jcb.29411
- Wang P, Xu S, Xu J, Xin Y, Lu Y, Zhang H, Zhou B, Xu H, Sheu SS, Tian R, et al. Elevated MCU expression by CaMKIIdB limits pathological cardiac remodeling. Circulation 2022;145:1067-83. https://doi.org/10.1161/CIRCULATIONAHA.121.055841
- Lu T, Zhang Y, Su Y, Zhou D, Xu Q. Role of store-operated Ca2+ entry in cardiovascular disease. Cell Commun Signal 2022;20:33.
- Bootman MD, Rietdorf K. Tissue specificity: store-operated Ca2+ entry in cardiac myocytes. Adv Exp Med Biol 2017;993:363-87. https://doi.org/10.1007/978-3-319-57732-6_19
- Ambudkar IS, de Souza LB, Ong HL. TRPC1, Orai1, and STIM1 in SOCE: friends in tight spaces. Cell Calcium 2017;63:33-9. https://doi.org/10.1016/j.ceca.2016.12.009
- Correll RN, Goonasekera SA, van Berlo JH, Burr AR, Accornero F, Zhang HY, Makarewich CA, York AJ, Sargent MA, Chen XW, et al. STIM1 elevation in the heart results in aberrant Ca2+ handling and cardiomyopathy. J Mol Cell Cardiol 2015;87:38-47. https://doi.org/10.1016/j.yjmcc.2015.07.032
- Luik RM, Wang B, Prakriya M, Wu MM, Lewis RS. Oligomerization of STIM1 couples ER calcium depletion to CRAC channel activation. Nature 2008;454:538-42. https://doi.org/10.1038/nature07065
- Jardin I, Albarran L, Salido GM, Lopez JJ, Sage SO, Rosado JA. Fine-tuning of store-operated calcium entry by fast and slow Ca2+-dependent inactivation: involvement of SARAF. Biochim Biophys Acta Mol Cell Res 2018;1865:463-9. https://doi.org/10.1016/j.bbamcr.2017.12.001
- Collins HE, Zhu-Mauldin X, Marchase RB, Chatham JC. STIM1/Orai1-mediated SOCE: current perspectives and potential roles in cardiac function and pathology. Am J Physiol Heart Circ Physiol 2013;305:H446-58. https://doi.org/10.1152/ajpheart.00104.2013
- Eisner DA, Caldwell JL, Kistamas K, Trafford AW. Calcium and excitation-contraction coupling in the heart. Circ Res 2017;121:181-95. https://doi.org/10.1161/CIRCRESAHA.117.310230
- Nan J, Li J, Lin Y, Saif Ur Rahman M, Li Z, Zhu L. The interplay between mitochondria and store-operated Ca2+ entry: emerging insights into cardiac diseases. J Cell Mol Med 2021;25:9496-512. https://doi.org/10.1111/jcmm.16941
- Norman R, Fuller W, Calaghan S. Caveolae and the cardiac myocyte. Curr Opin Physiol 2018;1:59-67. https://doi.org/10.1016/j.cophys.2017.08.005
- Yang Y, Ma Z, Hu W, Wang D, Jiang S, Fan C, Di S, Liu D, Sun Y, Yi W. Caveolin1/-3: therapeutic targets for myocardial ischemia/reperfusion injury. Basic Res Cardiol 2016;111:45.
- Sowa G. Caveolae, caveolins, cavins, and endothelial cell function: new insights. Front Physiol 2012;2:120.
- Yeh YC, Parekh AB. Distinct structural domains of caveolin-1 independently regulate Ca2+ release-activated Ca2+ channels and Ca2+ microdomain-dependent gene expression. Mol Cell Biol 2015;35:1341-9. https://doi.org/10.1128/MCB.01068-14
- Takaguri A, Kamato M, Satoh Y, Ohtsuki K, Satoh K. Effect of alteration of caveolin-1 expression on doxorubicin-induced apoptosis in H9c2 cardiac cells. Cell Biol Int 2015;39:1053-60. https://doi.org/10.1002/cbin.10478
- Gao Y, Chu M, Hong J, Shang J, Xu D. Hypoxia induces cardiac fibroblast proliferation and phenotypic switch: a role for caveolae and caveolin-1/PTEN mediated pathway. J Thorac Dis 2014;6:1458-68.
- Li HX, Han SY, Ma X, Zhang K, Wang L, Ma ZZ, Tu PF. The saponin of red ginseng protects the cardiac myocytes against ischemic injury in vitro and in vivo. Phytomedicine 2012;19:477-83. https://doi.org/10.1016/j.phymed.2012.01.002
- Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-93. https://doi.org/10.1016/S0006-2952(99)00212-9
- Wen Z, Mai Z, Zhu X, Wu T, Chen Y, Geng D, Wang J. Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway. Stem Cell Res Ther 2020;11:36.
- Bakhshi FR, Mao M, Shajahan AN, Piegeler T, Chen Z, Chernaya O, Sharma T, Elliott WM, Szulcek R, Bogaard HJ, et al. Nitrosation-dependent caveolin 1 phosphorylation, ubiquitination, and degradation and its association with idiopathic pulmonary arterial hypertension. Pulm Circ 2013;3:816-30. https://doi.org/10.1086/674753
- Dong Y, Chen HW, Gao JL, Liu YM, Li J, Wang J. Molecular machinery and interplay of apoptosis and autophagy in coronary heart disease. J Mol Cell Cardiol 2019;136:27-41. https://doi.org/10.1016/j.yjmcc.2019.09.001
- Tardy AL, Bois De Fer B, Canigueral S, Kennedy D, Scholey A, Hitier S, Aran A, Pouteau E. Reduced self-perception of fatigue after intake of Panax ginseng root extract (G115(®)) formulated with vitamins and minerals-an open-label study. Int J Environ Res Public Health 2021;18:6257.
- Chen YM, Wang IL, Zhou S, Tsai TY, Chiu YS, Chiu WC. Six weeks of Jilin ginseng root supplementation attenuates drop jump-related muscle injury markers in healthy female college students. Food Funct 2021;12:1458-68. https://doi.org/10.1039/D0FO03146A
- Lee ES, Yang YJ, Lee JH, Yoon YS. Effect of high-dose ginsenoside complex (UG0712) supplementation on physical performance of healthy adults during a 12-week supervised exercise program: a randomized placebo-controlled clinical trial. J Ginseng Res 2018;42:192-8. https://doi.org/10.1016/j.jgr.2017.03.001
- Hitier S, Aran A, Pouteau E, Kim JY, Park JY, Kang HJ, Kim OY, Lee JH. Beneficial effects of Korean red ginseng on lymphocyte DNA damage, antioxidant enzyme activity, and LDL oxidation in healthy participants: a randomized, double-blind, placebo-controlled trial. Int J Environ Res Public Health 2012;11:47.
- Lee NH, Jung HC, Lee S. Red ginseng as an ergogenic aid: a systematic review of clinical trials. J Exerc Nutrition Biochem 2016;20:13-9. https://doi.org/10.20463/jenb.2016.0034
- Reay JL, Scholey AB, Milne A, Fenwick J, Kennedy DO. Panax ginseng has no effect on indices of glucose regulation following acute or chronic ingestion in healthy volunteers. Br J Nutr 2009;101:1673-8. https://doi.org/10.1017/S0007114508123418
- Ghavami A, Ziaei R, Foshati S, Hojati Kermani MA, Zare M, Amani R. Benefits and harms of ginseng supplementation on liver function? A systematic review and meta-analysis. Complement Ther Clin Pract 2020;39:101173.
- Irfan M, Kwak YS, Han CK, Hyun SH, Rhee MH. Adaptogenic effects of Panax ginseng on modulation of cardiovascular functions. J Ginseng Res 2020;44:538-43. https://doi.org/10.1016/j.jgr.2020.03.001
- Park SH, Chung S, Chung MY, Choi HK, Hwang JT, Park JH. Effects of Panax ginseng on hyperglycemia, hypertension, and hyperlipidemia: a systematic review and meta-analysis. J Ginseng Res 2022;46:188-205. https://doi.org/10.1016/j.jgr.2021.10.002
- Schilling JM, Roth DM, Patel HH. Caveolins in cardioprotection - translatability and mechanisms. Br J Pharmacol 2015;172:2114-25. https://doi.org/10.1111/bph.13009
- Patel HH, Tsutsumi YM, Head BP, Niesman IR, Jennings M, Horikawa Y, Huang D, Moreno AL, Patel PM, Insel PA, et al. Mechanisms of cardiac protection from ischemia/reperfusion injury: a role for caveolae and caveolin-1. FASEB J 2007;21:1565-74. https://doi.org/10.1096/fj.06-7719com
- Jasmin JF, Rengo G, Lymperopoulos A, Gupta R, Eaton GJ, Quann K, Gonzales DM, Mercier I, Koch WJ, Lisanti MP. Caveolin-1 deficiency exacerbates cardiac dysfunction and reduces survival in mice with myocardial infarction. Am J Physiol Heart Circ Physiol 2011;300:H1274-81. https://doi.org/10.1152/ajpheart.01173.2010
- Yun U-J, Lee J-H, Koo KH, Ye S-K, Kim S-Y, Lee C-H, Kim Y-N. Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition. Biochem Pharmacol 2013;85:1441-53. https://doi.org/10.1016/j.bcp.2013.02.025
- Fathil MF, Md Arshad MK, Gopinath SC, Hashim U, Adzhri R, Ayub RM, Ruslinda AR, Nuzaihan MNM, Azman AH, Zaki M, et al. Diagnostics on acute myocardial infarction: cardiac troponin biomarkers. Biosens Bioelectron 2015;70:209-20. https://doi.org/10.1016/j.bios.2015.03.037
- Takahashi N, Ogita M, Suwa S, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Fujimoto K, et al. Prognostic impact of B-type natriuretic peptide on long-term clinical outcomes in patients with non-ST-segment elevation acute myocardial infarction without creatine kinase elevation. Int Heart J 2020;61:888-95. https://doi.org/10.1536/ihj.20-190
- Chen X, Zhang X, Kubo H, Harris DM, Mills GD, Moyer J, Berretta R, Potts ST, Marsh JD, Houser SR. Ca2+ influx-induced sarcoplasmic reticulum Ca2+ overload causes mitochondrial-dependent apoptosis in ventricular myocytes. Circ Res 2005;97:1009-17. https://doi.org/10.1161/01.RES.0000189270.72915.D1
- Zhong GG, Sun CW, Li YY, Qi H, Zhao CY, Jiang Y, Wang XM, Yang SJ, Li H. Calcium channel blockade and anti-free-radical actions of panaxadiol saponins Rb1, Rb2, Rb3, Rc, and Rd. Acta Pharmacologica Sinica 1995;16:255-60.
- Liu Z, Song L, Zhang P, Cao Z, Hao J, Tian Y, Luo A, Zhang P, Ma J. Ginsenoside Rb1 exerts antiarrhythmic effects by inhibiting INa and ICaL in rabbit ventricular myocytes. Sci Rep 2019;9:20425.
- Lu C, Sun Z, Wang L. Inhibition of L-type Ca2+ current by ginsenoside Rd in rat ventricular myocytes. J Ginseng Res 2015;39:169-77. https://doi.org/10.1016/j.jgr.2014.11.003
- Zhang WJ, Li L, Zhao CY, Li X, Zhao M, Zhong GG. Effects of panaxadiol saponins monomer Rb1 on action potential and L-type calcium channel in ischemic cardiomyocytes. J Jilin Univ Med Edit 2007:978-81.
- Lee JH, Jeong SM, Kim JH, Lee BH, Yoon IS, Lee JH, Choi SH, Lee SM, Park YS, Lee JH, et al. Effects of ginsenosides and their metabolites on voltage-dependent Ca2+ channel subtypes. Mol Cells 2006;21:52-62. https://doi.org/10.1016/s1016-8478(23)12902-5
- He F, Wu Q, Xu B, Wang X, Wu J, Huang L, Cheng J. Suppression of Stim1 reduced intracellular calcium concentration and attenuated hypoxia/reoxygenation induced apoptosis in H9C2 cells. Biosci Rep 2017;37.
- Tian W, Liu SY, Zhang M, Meng JR, Tang N, Feng YD, Sun Y, Gao YY, Zhou L, Cao W, et al. TRPC1 contributes to endotoxemia-induced myocardial dysfunction via mediating myocardial apoptosis and autophagy. Pharmacol Res 2022;181:106262.
- Chen Z, Wu J, Li S, Liu C, Ren Y. Inhibition of myocardial cell apoptosis is important mechanism for ginsenoside in the limitation of myocardial ischemia/reperfusion injury. Front Pharmacol 2022;13:806216.
- Brazer SC, Singh BB, Liu X, Swaim W, Ambudkar IS. Caveolin-1 contributes to assembly of store-operated Ca2+ influx channels by regulating plasma membrane localization of TRPC1. J Biol Chem 2003;278:27208-272015. https://doi.org/10.1074/jbc.M301118200
- Chaudhary KR, Cho WJ, Yang F, Samokhvalov V, El-Sikhry HE, Daniel EE, Seubert JM. Effect of ischemia reperfusion injury and epoxyeicosatrienoic acids on caveolin expression in mouse myocardium. J Cardiovasc Pharmacol 2013;61:258-63. https://doi.org/10.1097/FJC.0b013e31827afcee
- Schilling JM, Dhanani M, Haushalter KJ, Howell SA, Verma R, Niesman IR, Zemljic-Harpf AE, Patel HH. Loss of caveolin-1 alters cardiac mitochondrial function and increases susceptibility to stress. J Mol Cell Cardiol 2017;112. 165-165. https://doi.org/10.1016/j.yjmcc.2017.07.103
- Singh S, Mabalirajan U. Mitochondrial calcium in command of juggling myriads of cellular functions. Mitochondrion 2021;57:108-18. https://doi.org/10.1016/j.mito.2020.12.011
- Shivshankar P, Halade GV, Calhoun C, Escobar GP, Mehr AJ, Jimenez F, Martinez C, Bhatnagar H, Mjaatvedt CH, Lindsey ML, et al. Caveolin-1 deletion exacerbates cardiac interstitial fibrosis by promoting M2 macrophage activation in mice after myocardial infarction. J Mol Cell Cardiol 2014;76:84-93. https://doi.org/10.1016/j.yjmcc.2014.07.020
- Wang Q, Fu W, Yu X, Xu H, Sui D, Wang Y. Ginsenoside Rg2 alleviates myocardial fibrosis by regulating TGF-b1/Smad signalling pathway. Pharm Biol 2021;59:106-13. https://doi.org/10.1080/13880209.2020.1867197
- Wang QW, Yu XF, Xu HL, Zhao XZ. Ginsenoside Re improves isoproterenol-induced myocardial fibrosis and heart failure in rats. Evid Based Complement Alternat Med 2019:3714508.
- Lai Q, Liu FM, Rao WL, Yuan GY, Fan ZY, Zhang L, et al. Aminoacylase-1 plays a key role in myocardial fibrosis and the therapeutic effects of 20(S)-ginsenoside Rg3 in mouse heart failure. Acta Pharmacol Sin 2022;43(8):2003-2015. https://doi.org/10.1038/s41401-021-00830-1
- Irfan M, Kim M, Rhee MH. Anti-platelet role of Korean ginseng and ginsenosides in cardiovascular diseases. J Ginseng Res 2020;44:24-32. https://doi.org/10.1016/j.jgr.2019.05.005
- Li W, Wu Y, Cai S, Tang C. Comparative effects of decreasing viscosity in different preparations of Chinese angelica root and ginseng. Zhong Yao Cai 2001;24:581-3.
- Chen IJ, Chang MY, Chiao SL, Chen JL, Yu CC, Yang SH, Liu JM, Hung CC, Yang RC, Chang HC, et al. Korean red ginseng improves blood pressure stability in patients with intradialytic hypotension. Evid Based Complement Alternat Med 2012;2012:595271.
- Yu Z, Han SY, Li HX, Tu PF. Effects of ginseng and safflower extractions on blood stream kinetics of heart in myocardial ischemia dogs. Chin J Basic Med Tradit Chin Med 2012;18:777-82.